摘要
[目的]研究逆行胰胆管造影(ERCP)术后放置胰管支架对胰腺炎高危患者ERCP术后胰腺炎(PEP)和高淀粉酶血症的预防作用。[方法]回顾性分析2006年3月~2012年6月在我科住院需行ERCP治疗的PEP高危患者123例的临床资料。根据术后是否放置胰管支架,将其分为胰管支架组53例(放置支架)和对照组70例(未放置支架)。以Cotton标准诊断PEP和高淀粉酶血症,比较2组患者术前、术后6h血清淀粉酶水平,评估2组患者术后PEP和高淀粉酶血症的发生率;评估ERCP术后血清淀粉酶恢复正常的时间、PEP的发生率,分析PEP发生的高危因素。[结果]所有患者术前血清淀粉酶均正常;ERCP术后6h血清淀粉酶水平:胰管支架组(357.7±198.3)U/L,低于对照组(484.7±376.9)U/L;术后PEP的发生率:胰管支架组13例(24.5%),对照组39例(55.7%);术后高淀粉酶血症的发生率:胰管支架组22例(40.2%),对照组14例(20.0%);重症胰腺炎的发生率:胰管支架组0例(00.0%),对照组6例(8.57%);术后淀粉酶恢复正常的时间:胰管支架组为2.45d;对照组为7.85d,以上指标2组比较差异均有统计学意义(均P<0.05)。[结论]ERCP术后在高危PEP人群中应用胰管支架置入术可有效降低PEP和高淀粉酶血症患者的淀粉酶水平;明显缩短术后PEP及高淀粉酶血症恢复正常的时间;明显缩短患者总住院时间。
[Objective]To investigate the preventive effect of pancreatic stent placement on p0st-ERCP pancreatitis (PEP) and hyperamylasemia. [Methods]We retrospectively analyzed the 123 patients with high-risk PEP between March 2006 and June 2012. The patients were divided into stent placement group (n = 53) and non-stent placement group (n=70). PEP and hyperamylasemia were diagnosed according to Cotton standard. Preoperative and 6-hours-postoperative serum amylase levels were obtained. Occurrence of PEP and hyperamylasemia and prognosis were assessed. The high-risk factors influencing PEP were ana- lyzed. [Results]Serum amylase levels before ERCP of both groups were normal. The serum amylase level of stent placement 6 hours after surgery was / [(357.7±198.3)U/L], which was lower than that of non-stent placement group [(484.7+376.9)U/L] (P〈0.05). The incidence of PEP of stents placement group (24. 5%) was lower than that of control group (55.7%)(P〈0.05). Post-ERCP hyperamylasemia incidence of stents placement (40. 2%)was higher than that of the control group (20.0%) (P〈0.05). [Conclusion]Pancreatic stents placement after ERCP can effectively reduce the incidence of PEP and reduce amylase levels of patients with hyperamylasemia.
出处
《中国中西医结合消化杂志》
CAS
2013年第3期146-149,共4页
Chinese Journal of Integrated Traditional and Western Medicine on Digestion
关键词
胰腺炎
逆行胰胆管造影术
胰管支架
高淀粉酶血症
pancreatitis
endoscopic retrograde cholangiopancreatography
pancreatic stent place-ment
hyperamylasemia